ISOPTO ATROPINE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Isopto Atropine, and when can generic versions of Isopto Atropine launch?
Isopto Atropine is a drug marketed by Alcon Labs Inc and is included in one NDA.
The generic ingredient in ISOPTO ATROPINE is atropine sulfate. There are twenty-three drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the atropine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Isopto Atropine
A generic version of ISOPTO ATROPINE was approved as atropine sulfate by HOSPIRA on July 9th, 2001.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for ISOPTO ATROPINE?
- What are the global sales for ISOPTO ATROPINE?
- What is Average Wholesale Price for ISOPTO ATROPINE?
Summary for ISOPTO ATROPINE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 57 |
Patent Applications: | 1,660 |
Drug Prices: | Drug price information for ISOPTO ATROPINE |
What excipients (inactive ingredients) are in ISOPTO ATROPINE? | ISOPTO ATROPINE excipients list |
DailyMed Link: | ISOPTO ATROPINE at DailyMed |
Pharmacology for ISOPTO ATROPINE
Drug Class | Anticholinergic Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Antagonists Cholinergic Muscarinic Antagonists |
US Patents and Regulatory Information for ISOPTO ATROPINE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alcon Labs Inc | ISOPTO ATROPINE | atropine sulfate | SOLUTION/DROPS;OPHTHALMIC | 208151-001 | Dec 1, 2016 | AT2 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |